Literature DB >> 11010597

Regional mucociliary clearance in patients with cystic fibrosis.

M Robinson1, S Eberl, C Tomlinson, E Daviskas, J A Regnis, D L Bailey, P J Torzillo, M Menache, P T Bye.   

Abstract

This paper reports on a large retrospective analysis of mucociliary clearance (MCC) studies in a group of 59 patients with cystic fibrosis (CF) and 17 age-matched healthy subjects. As many of the CF patients were studied on multiple occasions, a total of 184 patient studies are presented. MCC was measured using a radioaerosol and gamma camera technique. In addition to whole lung clearance, MCC was measured from the central, intermediate, peripheral, basal, mid and apical regions of the lung. MCC was markedly decreased in the CF patient group. Not only was whole lung clearance (14.2 +/- 1.4% vs. 28.0 +/- 3.7%) impaired, but also clearance from the central (19.1 +/- 1.9% vs. 35.6 +/- 4.3%), intermediate (10.7 +/- 1.6% vs. 25.5 +/- 3.7%), apical (12.4 +/- 2.6% vs. 31.6 +/- 4.6%) and mid (14.0 +/- 1.9% vs. 30.4 +/- 4.0%) regions. Attempts were made to identify factors that may have influenced MCC in both the normal subjects and CF patients. Age, gender, body mass index, patient genotype, penetration index, spontaneous cough, and various lung function parameters were entered into a stepwise multiple regression model, but none of the factors proved to be statistically important in determining MCC. Both intrasubject repeatability and intersubject variability estimates are presented for the patients and normal subjects that had multiple studies. The values were found to be remarkably similar for both CF patients and normal subjects and for both intra- and intersubject repeatability. With marked deviation from normal ranges and good repeatability, the measurement of MCC in CF patients would seem to be a valuable outcome measure for clinical trials involving new pharmaceuticals and physical therapy designed to improve removal of secretions from the airways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11010597     DOI: 10.1089/089426800418604

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  10 in total

Review 1.  New therapeutic approaches for cystic fibrosis lung disease.

Authors:  Jane C Davies
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Imaging the postdeposition dispersion of an inhaled surfactant aerosol.

Authors:  Timothy E Corcoran; Kristina M Thomas; Stephen Garoff; Robert D Tilton; Todd M Przybycien; Joseph M Pilewski
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-03-06       Impact factor: 2.849

3.  Restoration of mucociliary transport in the fluid-depleted trachea by surface-active instillates.

Authors:  Stephen T Ballard; James C Parker; Charles R Hamm
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-15       Impact factor: 6.914

4.  Genetic examination of children suffering from cystic fibrosis.

Authors:  Ediba Saracević; Amira Redzić
Journal:  Bosn J Basic Med Sci       Date:  2005-02       Impact factor: 3.363

Review 5.  Regulation of the epithelial Na+ channel and airway surface liquid volume by serine proteases.

Authors:  Erol A Gaillard; Pradeep Kota; Martina Gentzsch; Nikolay V Dokholyan; M Jackson Stutts; Robert Tarran
Journal:  Pflugers Arch       Date:  2010-04-18       Impact factor: 3.657

6.  Quantitative imaging of airway liquid absorption in cystic fibrosis.

Authors:  Landon W Locke; Michael M Myerburg; Matthew R Markovetz; Robert S Parker; Lawrence Weber; Michael R Czachowski; Thomas J Harding; Stefanie L Brown; Joseph A Nero; Joseph M Pilewski; Timothy E Corcoran
Journal:  Eur Respir J       Date:  2014-04-17       Impact factor: 16.671

7.  Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.

Authors:  Landon W Locke; Michael M Myerburg; Daniel J Weiner; Matthew R Markovetz; Robert S Parker; Ashok Muthukrishnan; Lawrence Weber; Michael R Czachowski; Ryan T Lacy; Joseph M Pilewski; Timothy E Corcoran
Journal:  Eur Respir J       Date:  2016-03-23       Impact factor: 16.671

8.  A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in cystic fibrosis.

Authors:  Matthew R Markovetz; Timothy E Corcoran; Landon W Locke; Michael M Myerburg; Joseph M Pilewski; Robert S Parker
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 9.  Novel outcome measures for clinical trials in cystic fibrosis.

Authors:  Harm A W M Tiddens; Michael Puderbach; Jose G Venegas; Felix Ratjen; Scott H Donaldson; Stephanie D Davis; Steven M Rowe; Scott D Sagel; Mark Higgins; David A Waltz
Journal:  Pediatr Pulmonol       Date:  2014-12-30

10.  Visualization and quantification of injury to the ciliated epithelium using quantitative flow imaging and speckle variance optical coherence tomography.

Authors:  Ute A Gamm; Brendan K Huang; Emily K Mis; Mustafa K Khokha; Michael A Choma
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.